US FDA Commissioner Scott Gottlieb's highly discussed activities on generic drugs are continuing to take shape, as the agency has formally announced a public meeting seeking stakeholder feedback on eliminating a variety of barriers to facilitate generic competition.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?